No products in the cart.

Chapter 38. Hormone Replacement Therapy and Osteoporosis

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 4th Edition by Teri Moser Woo

$2.99

Chapter 38. Hormone Replacement Therapy and Osteoporosis

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

Multiple Choice

Identify the choice that best completes the statement or answers the question.

 

____     1.   The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing:

1. Cardiovascular risk
2. Risk of stroke or other thromboembolic event
3. Breast cancer
4. Vasomotor symptoms

 

 

____     2.   The optimal maximum time frame for HRT or estrogen replacement therapy (ERT) is:

1. 2 years
2. 5 years
3. 10 years
4. 15 years

 

 

____     3.   Dosage changes of conjugated equine estrogen (Premarin) are made at _________ intervals.

1. 1 to 2 week
2. 2 to 4 week
3. 6 to 8 week
4. 12 week

 

 

____     4.   The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness is:

1. Ability to deliver higher doses of estrogen in a non-oral form
2. The vaginal cream formula provides moisture to the vaginal area
3. Relief of symptoms without increasing cardiovascular risk
4. All of the above

 

Answer Section

 

MULTIPLE CHOICE

 

  1. ANS:  4                    PTS:   1

 

  1. ANS:  2                    PTS:   1

 

  1. ANS:  3                    PTS:   1

 

  1. ANS:  3                    PTS:   1

Additional information

Add Review

Your email address will not be published. Required fields are marked *